• World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
  • World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
  • World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
  • World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
  • World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
  • World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract

World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract

Certification: ISO, FDA, Hahal, Food Manufacturing License, Business Licens
Assay Method: HPLC, UV
Application Form: Tablet, Capsule
Application: Food, Health Care Products, Medicine
State: Powder
Extract Source: Sophora Flavescens Alt
Samples:
US$ 0/20G 1 20G(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company

Basic Info.

Model NO.
HWW-2023012401
Product Name
Sophora Root Extract
Latin Name
Sophora Flavescens Alt
Used Part
Root
Appearance
Brownish Yellow to White Fine Powder
Payment
T/T in Advance
Shelf Life
24 Months
Delivery Time
3-5 Working Days
Free Sample
Available
Transport Package
25kg/Drum
Specification
98% matrine / 98% Oxymatrine
Origin
Hunan, China
Production Capacity
8t/Month

Product Description

Product Description
Product Name Sophora Root Extract 
Botanical Name Sophora flavescens Alt
Part Used Root
Appearance Brownish Yellow to White powder
Specification 4:1 10:1
Straight Powder

98% matrine 
98% Oxymatrine
98% Sophoridine
Storage Period 24 Months
Package 1kg/bag 25kg/drum
Storage Conditions Store in cool and dry places. Keep away from strong light and heat.
Description:
Deciduous subshrub, 80~120cm high. The root is cylindrical, the outer skin is yellow, the cross section is yellow and white, and the taste is extremely bitter. Odd pinnate compound leaves, 20~25cm long, alternate; with 11~19 leaflets, leaf blade lanceolate to linear-lanceolate, 3~4cm long, 1.2~2cm wide, apex acuminate, base round, short stalks, entire, densely pubescent on the back; stipules linear. Racemes terminal, short hairs, bracts linear; calyx campanulate, flat, 6~7mm long, 5-lobed; corolla butterfly-shaped, yellowish white; flag petal spatulate, wing petal aurless, equal to the length of keel; stamens 10, filaments separated; ovary stalk with fine hairs. The pods are striped, with a long beak at the apex, and constricted between the seeds, slightly inconspicuous rosary. The flowering period is from June to August and the fruiting period is from August to September. 

Health Benefits
1. protective effect of gastric mucosa 
Sophora flavescens extract has obvious protective effect on gastric mucosal injury caused by hydrochloric acid, ethanol and indomethacin, and its main component is flavanone compounds. Recent studies have shown that matrine is also one of the effective components of Sophora flavescens against gastric mucosal injury. It has obvious protective effect on gastric mucosal injury caused by stress, hydrochloric acid, ethanol and indomethacin in rats. It indicates that Sophora flavescens may have some anti-ulcer effect. 

2. Anti-inflammatory effect 
Matrine has obvious antagonistic use of acute exudative inflammation caused by various inflammatory agents (croton oil, glacial acetic acid, carrageenan, egg white), and has similar effects to hydrocortison. Its anti-inflammatory mechanism has nothing to do with the pituitary-adrenal cortex system. Matrine still has a significant anti-inflammatory effect on mice with adrenal glands removed. Studies have shown that this product has the characteristics of non-steroidal anti-inflammatory drugs. In addition, matrine has a stabilizing effect on the red blood cell membrane, and drugs that have a stabilizing effect on the red blood cell often have a stabilizing effect on the lysosomal membrane, thereby reducing the release of inflammatory mediators and achieving anti-inflammatory purposes. 

3. Anti-tumor effect 
Matrine mice were injected intraperitoneally with 500 μg/day, the survival rate was 40%, while the control group all died within 23 days. Oxymatrine has no effect on this. Matrine can reduce the proliferation of P815 tumor cells by mouse peritoneal macrophages in vitro. Sophorine also has anti-cancer activity. Matrine, oxymatrine, sophocarpine and their mixed A, B and C bases in different proportions have different degrees of inhibition on S180 solid tumors. Matrine has a significant inhibitory effect on the colony production rate of peripheral multidirectional hematopoietic progenitor cells in chronic myeloid leukemia. Sophora flavescens decoction acts on human promyelocytic leukemia cells cultured in vitro, which can significantly induce leukemia cells to differentiate into mononuclear macrophages. 

4. Leukocyte-increasing effect 
Oxymatrine can prevent mice from leukopenia caused by MMC and cyclophosphamide. Intravenous or intramuscular injection of matrine and oxymatrine have a significant effect on the number of white blood cells in the peripheral blood of normal rabbits. The effect, maintenance time and peak white blood cell count of oxymatrine on normal rabbits are basically the same within 18 days after administration, the whitening effect is better than shark liver alcohol. 

5. Effect on the cardiovascular system
Intravenous injection of matrine and oxymatrine significantly resists arrhythmia induced by aconitine and chloroform-epinephrine in rats; intraperitoneal injection significantly resists chloroform-induced ventricular fibrillation in mice, and also increases the amount of aconitine-induced arrhythmia in rats, and resists the arrhythmia induced by barium chloride and the arrhythmia induced by ligating the anterior descending branch of the coronary artery in rats. 

6. The effect of relieving asthma and expectorant matrine is mainly through the excitation of β receptors, especially the β receptors in the excitation center, to relieve bronchospasm and inhibit the release of antibodies and slow response substances to produce asthma.

 7. The total alkaloids of Sophora flavescens can obviously inhibit the free activity of mice; the passive activity of mice is obviously inhibited; high dose can inhibit the fighting and aggressive behavior of lonely mice. 

8. Anti-allergic effect 
Matrine can reduce the release of allergic mediators, and its concentration of inhibiting 50% OT cell proliferation is 0.55~0.56 mg/ml; The concentration of inhibiting IL-2 yield is 0.1 mg/kg.

9. Immunosuppressive effects 
Matrine and oxymatrine have inhibitory effects on immune function of mice. 

10. Antifungal effect 
Sophora flavescens decoction has inhibitory effect on common skin fungi. 11. The antibacterial effect of Sophora flavescens extract has inhibitory effect on Staphylococcus, Pseudomonas aeruginosa, Mycobacterium tuberculosis, etc. 

12. Effects on the central nervous system 
Matrine was injected into rabbits, and central nerve paralysis was found, spasm occurred at the same time, and finally respiratory arrest and death. Injected into a frog, it is excited at the beginning, then paralyzed, breathing becomes slow and irregular, and then spasm occurs, so that breathing stops and dies. The onset of spasm may be caused by hyperreflexia in the spinal cord.
 
13. Antiarrhythmic effect 
Sophora flavescens has a good antagonistic effect on arrhythmia caused by aconitine, sympathetic amine and digitalis poisoning, and its effect is quite similar to quinidine. That is, by affecting the myocardial cell membrane potassium and sodium conduction system, the absolute refractory period of the myocardium is prolonged, and the stress is reduced, thereby inhibiting the ectopic pacing point and exerting an anti-arrhythmia effect. The active ingredient is preliminarily proved to be the alkaloid part contained. Because Sophora flavescens has no effect on the heart and heart rate of the frog heart and rat myocardium, it does not increase myocardial oxygen consumption and aggravate the shortcomings of heart failure and shock, which is worthy of attention for ischemic heart disease. 

14. Toxic effects of oral 
Sophora flavescens can cause poisoning, symptoms can be seen salivation, irregular pace, faster breathing, pulse, convulsions, and finally death. Rescue method: gastric lavage, catharsis, egg white, tannic acid, strong tea and intravenous glucose saline can be used when convulsions do not occur. Intramuscular injection of phenobarbita and other antispasmodic agents during convulsions, and respiratory stimulants when breathing disorders.
World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
 
World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
 
World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
 
World Well-Being Biotech CAS 519-02-8 98% Matrine CAS 16837-52-8 98% Oxymatrine CAS 6882-68-4 98% Sophoridine Sophora Root Extract
 
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory & Trading Company
Number of Employees
39
Year of Establishment
2013-01-10